Quarfloxin

DB06638InvestigationalSmall molecule

Investigated for use/treatment in leukemia (lymphoid).

Chemical structure of Quarfloxin
Primary indication
Investigated for use/treatment in leukemia (lymphoid).Curator reviewed
Formula / weight
C35H33FN6O3 · 604.686 g/mol (avg)
Also known as
Itarnafloxin
Code names
CX-3543

Resolves to

Compound
UNII8M31J5031QCAS865311-47-3ChEMBLCHEMBL3989407
Structure
InChIKeyWOQIDNWTQOYDLF-CGAIIQECSA-NSMILESCN1CCC[C@H]1CCNC(=O)C1=CN2C3=C(OC4=C2C(=CC(F)=C4N2CCC(C2)C2=CN=CC=N2)C1=O)C=C1C=CC=CC1=C3
Targets
P19338NCL

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Quarfloxin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In